Keyphrases
Interferon-α (IFN-α)
100%
Melanoma
100%
Cost-effectiveness
100%
Node-positive
100%
High-dose Interferon
100%
Adjuvant Interferon
100%
Quality-adjusted Life Years
45%
Incremental Cost-effectiveness Ratio
18%
Life-years Gained
18%
Stage IIIC
18%
Natural History
9%
Probability Estimates
9%
Older Patients
9%
Life Expectancy
9%
50 Years Old
9%
Markov Model
9%
Decision-analytic Model
9%
Patient-level Data
9%
Median Life
9%
High-risk Melanoma
9%
Stage III Melanoma
9%
Medicine and Dentistry
Melanoma
100%
Interferon Alfa
100%
Drug Megadose
100%
Interferon
100%
Cost-Effectiveness Analysis
100%
Health Care Cost
54%
Quality Adjusted Life Year
45%
Diseases
27%
Base
9%
Life Expectancy
9%
Nursing and Health Professions
Melanoma
100%
Drug Megadose
100%
Interferon
100%
Cost Effectiveness Analysis
100%
Alpha Interferon
100%
Quality Adjusted Life Year
45%
Diseases
27%
Incremental Cost-Effectiveness Ratio
18%
Base
9%
Life Expectancy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Interferon
100%
Interferon
100%
Melanoma
100%
Diseases
27%
Base
9%
Life Expectancy
9%